Live Breaking News & Updates on Researchers At Johannes Gutenberg University Mainz|Page 3

Stay updated with breaking news from Researchers at johannes gutenberg university mainz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inhibition of Meprin Β enzyme can trigger the development of Alzheimer's disease, cancer


Inhibition of Meprin Β enzyme can trigger the development of Alzheimer s disease, cancer
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.
These results could lead to the development of new drugs to treat serious diseases such as Alzheimer s and cancer. Meprin β releases proteins from cell membranes, thus controlling important physiological functions in the human body.
However, a dysregulation of this process can trigger the development of Alzheimer s and cancer. Meprin β is regulated by fetuin-B binding to the enzyme when required, thereby preventing the release of other proteins. Presenting their findings in the journal ....

Comunidad Autonoma De Cataluna , Emily Henderson , Researchers At Johannes Gutenberg University Mainz , Institute Of Molecular Biology Barcelona , Johannes Gutenberg University Mainz , Proceedings Of The National Academy Sciences , Mainz University , Molecular Biology , National Academy , Alzheimer 39s Disease , Molecular Biology , காமுனிடட தன்னாட்சி டி கடலுள் , எமிலி ஹென்டர்சன் , நிறுவனம் ஆஃப் மூலக்கூறு உயிரியல் பார்சிலோனா , மூலக்கூறு உயிரியல் , தேசிய கலைக்கழகம் ,

Inhibition of meprin β enzyme linked to the development of Alzheimer's disease analyzed


 E-Mail
IMAGE: Model of the molecular complex that results when the blood plasma protein fetuin-B (purple and pink) binds with the enzyme meprin β (other colors)
view more 
Credit: ill./©: Walter Stöcker
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings. These results could lead to the development of new drugs to treat serious diseases such as Alzheimer s and cancer. Meprin β releases proteins from cell membranes, thus controlling important physiological functions in the human body. However, a dysregulation of this process can trigger the development of Alzheimer s and cancer. Meprin β is regulated by fetuin-B binding to the enzyme when required, thereby preventing the release of other proteins. Presenting their findings in the journal ....

Comunidad Autonoma De Cataluna , Researchers At Johannes Gutenberg University Mainz , Institute Of Molecular Biology Barcelona , Proceedings Of The National Academy Sciences , Mainz University , Johannes Gutenberg University Mainz , Molecular Biology , National Academy , Molecular Biology , Medicine Health , Alzheimers Disease , காமுனிடட தன்னாட்சி டி கடலுள் , நிறுவனம் ஆஃப் மூலக்கூறு உயிரியல் பார்சிலோனா , மூலக்கூறு உயிரியல் , தேசிய கலைக்கழகம் ,